«This study provides evidence that a single dose of an antibody stimulates patients» immune response, enabling them to make new or
better antibodies against the virus,» explains Till Schoofs, a postdoctoral fellow and one of the study's first authors.
Not exact matches
«This was due to a belief that humans just don't make
good antibodies against HIV and also because the
virus is extremely changeable.»
It may
well be that the
antibodies found by the team weren't directed
against the Heartland
virus but some other agent; it's not uncommon for cross-reactivity to occur in serological tests.
In conclusion, the
antibodies characterized herein show promise for development as broadly reactive therapeutic agents
against the pandemic H1N1 influenza
virus, as
well as
against the majority of H1N1 and H5N1 influenza strains.
Those
antibodies could be used to develop vaccines to protect
against Zika, as
well as therapies to treat the
virus, according to the study, which was a collaboration between researchers at UNC's Gillings School of Global Public Health and the UNC School of Medicine.
Some veterinarians feel that senior dogs with a
good history of vaccinations may have enough
antibody titers
against the
viruses.